scholarly journals Routine first‐trimester combined screening for pre‐eclampsia: pregnancy‐associated plasma protein‐A or placental growth factor?

2021 ◽  
Author(s):  
L. Nöel ◽  
G. P. Guy ◽  
S. Jones ◽  
K. Forenc ◽  
E. Buck ◽  
...  
Keyword(s):  
Growth Factor ◽  
Plasma Protein ◽  
Protein A ◽  
First Trimester ◽  
Placental Growth Factor

scholarly journals First-trimester prediction of preeclampsia: A comparison between Pregnancy-associated plasma protein-A and Placental growth factor

2022 ◽  
Vol 226 (1) ◽  
pp. S454-S455
Author(s):  
Alexandre Fillion ◽  
Paul Guerby ◽  
Cédric Gasse ◽  
Francois Audibert ◽  
Amélie Boutin ◽  
...  
Keyword(s):  
Growth Factor ◽  
Plasma Protein ◽  
Protein A ◽  
First Trimester ◽  
Placental Growth Factor

scholarly journals Методика проведения скринингового исследования в первом триместре беременности с расчетом риска развития преэклампсии и задержки роста плода по алгоритму Фонда медицины плода (Fetal Medicine Foundation)

2018 ◽  
pp. 77-88
Keyword(s):  
Growth Factor ◽  
Plasma Protein ◽  
Protein A ◽  
Placental Growth Factor ◽  
Fetal Medicine

В статье представлено описание методики проведения раннего пренатального скрининга с расчетом индивидуального риска развития преэклампсии и задержки роста плода в 11+1–13+6 нед беременности, проводимого согласно алгоритму Фонда меди­цины плода (Fetal Medicine Founda­tion) одновременно со скринингом на наличие у плода синдромов Дауна, Эдвардса и Патау. Расчет индивидуального риска развития преэклампсии и задержки роста плода осуществляется с учетом материнских характеристик, среднего артериального давления, пульсационного индекса в маточных артериях, ассоциированного с беременностью протеина А (pregnancy-associated plasma protein-A (РАРР-А)) и плацентарного фактора роста (placental growth factor (PlGF)) в сыворотке матери. Представлена характеристика каждого из этих параметров в предсказательной оценке риска развития преэклампсии и задержки роста плода. Отражены диагностические возможности данного алгоритма и его преимущества над классическими системами формирования групп высокого риска по развитию преэклампсии, учитывающих только материнские характеристики. Ключевые сло­ва: комбинированный скрининг первого триместра беременности, задержка роста плода, преэклампсия, среднее артериальное давление, пульсационный индекс в маточных артериях, ассоциированный с беременностью протеин А (РАРР-А), плацентарный фактор роста (PlGF).

scholarly journals Association of serum placental growth factor and pregnancy associated plasma protein A between 11 to 14 weeks and pre-eclampsia

2021 ◽  
Vol 10 (5) ◽  
pp. 1925
Author(s):  
Namrata Kumar ◽  
Vinita Das ◽  
Anjoo Agrawal ◽  
Amita Pandey ◽  
Smriti Agrawal
Keyword(s):  
Growth Factor ◽  
Plasma Protein ◽  
Protein A ◽  
Placental Growth Factor ◽  
Detection Rates ◽  
Crown Rump Length ◽  
Study Association ◽  
One Year ◽  
Medical University ◽  
Potential Tool

Background: Pre eclampsia complicates around 5-10% of pregnancies worldwide. Many countries in the world are far away of having interventions to predict and prevent preeclampsia. A number of biochemical, biophysical and sonographic parameters are emerging as a potential tool which can help us in a long way. This study was aimed to study association of biochemical markers of preeclampsia in early pregnancy with the development of preeclampsia.Methods: This cohort study was conducted over a period of one year in the Department of Obstetrics and Gynecology at King George’s Medical University, Lucknow.Results: Total number of women enrolled at 11-14 weeks were 56. The mean age of women enrolled was 28±4.2 years. Out of total 44.6% women were nulliparous. Mean crown rump length at testing was 60.55±11.26mm. There was a significant correlation between the levels of Placental growth factors and development of PE (p<0.01) and especially severe early onset disease, however we did not found a significant correlation between Pregnancy associated plasma protein and Preeclampsia.Conclusions: Placental growth factor is an emerging marker which could be incorporated in essential bundle of care at 11 to 14 weeks testing in order to enhance the detection rates of preeclampsia.

scholarly journals Pregnancy Associated Plasma Protein-A and Placental Growth Factor in a Sub-Saharan African Population: A Nested Cross-Sectional Study

PLoS ONE ◽  
2016 ◽  
Vol 11 (8) ◽  
pp. e0159592 ◽  
Author(s):  
Joyce L. Browne ◽  
Kerstin Klipstein-Grobusch ◽  
Maria P. H. Koster ◽  
Dhivya Ramamoorthy ◽  
Edward Antwi ◽  
...  
Keyword(s):  
Growth Factor ◽  
Plasma Protein ◽  
Protein A ◽  
Cross Sectional Study ◽  
Placental Growth Factor ◽  
African Population ◽  
Sectional Study ◽  
Cross Sectional ◽  
Sub Saharan

scholarly journals 72 Pregnancy associated plasma protein-A and placental growth factor in a sub-Saharan African population: A nested cross-sectional study

2016 ◽  
Vol 6 (3) ◽  
pp. 172-173 ◽  
Author(s):  
Joyce L. Browne ◽  
Kerstin Klipstein-Grobusch ◽  
Maria P.H. Koster ◽  
Dhivya Ramamoorthy ◽  
Edward Antwi ◽  
...  
Keyword(s):  
Growth Factor ◽  
Plasma Protein ◽  
Protein A ◽  
Cross Sectional Study ◽  
Placental Growth Factor ◽  
African Population ◽  
Sectional Study ◽  
Cross Sectional ◽  
Sub Saharan

scholarly journals 165. Improved prediction of gestational hypertension by inclusion of placental growth factor and Pregnancy Associated Plasma Protein-A in a sample of Ghanaian women

2018 ◽  
Vol 13 ◽  
pp. S90
Author(s):  
Edward Antwi ◽  
Kerstin Klipstein-Grobusch ◽  
Joyce Browne ◽  
Peter Schielen ◽  
Kwadwo Koram ◽  
...  
Keyword(s):  
Growth Factor ◽  
Plasma Protein ◽  
Gestational Hypertension ◽  
Protein A ◽  
Placental Growth Factor ◽  
Ghanaian Women
Sign in / Sign up

Export Citation Format

Share Document